Carcinogenicity of dermally administered 1,2-dihydro-2,2,4-trimethylquinoline monomer in F344 rats and B6C3F1 mice

Journal of Applied Toxicology

Volumn 19, Issue 2, 1999, Pages 125-132

  Irwin, Richard D ^a   French, John E ^a   Elwell, Michael ^a   Haseman, Joe ^a   Braun, A G ^b   Voelker, F A ^b  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b TSI Mason Laboratories   (United States)

Author keywords

Carcinogenicity; Dermal; Trimethylquinoline

Indexed keywords

ACETONE; DIMETHYLBENZ[A]ANTHRACENE; MONOMER; PHORBOL 13 ACETATE 12 MYRISTATE; QUINOLONE DERIVATIVE;

ACANTHOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CARCINOGENICITY; CONTROLLED STUDY; HYPERKERATOSIS; KIDNEY ADENOMA; KIDNEY CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN TUMOR; SURVIVAL;

ANIMALIA;

EID: 0032994598     PISSN: 0260437X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1099-1263(199903/04)19:2<123::aid-jat550>3.0.co;2-%23     Document Type: Article

References (28)

1. HSDB, Hazardous Substances Data Base (1995).
2. G. Ya. Kel'man, The toxicity of certain anti-oxidants used in the rubber industry. Hyg. Sanit. 31, 183-187 (1966).
3. Y. M. Ioannou, L. T. Burka, J. M. Sanders, M. P. Moorman and H. B. Matthews, Absorption, distribution, metabolism, and excretion of 1,2-dihydro-2,2,4-trimethylquinoline in the male F344 rat. Drug Metab. Dispos. 15, 367-373 (1987).
4. 1 mice (skin paint). Toxicologist 7, 38 (1987).
5. P. V. Shah, H. L. Fisher, M. R. Sumler, M. Sanders, Y. M. Ioannou and L. L. Hall, Dermal absorption and disposition of 1,2-dihydro-2,2,4-trimethylquinoline in Fischer rats. Toxicologist 7, 244 (1987).
6. D. R. Cox, Regression models and life tables. J. R. Stat. Soc. B34, 187-220 (1972).
7. R. E. Tarone, Tests for trend in life table analysis. Biometrica 62, 679-682 (1975).
8. G. E. Dinse and S. W. Lagakos, Regression analysis of tumor prevalence data. Appl. Stat. 32, 236-248 (1983).
9. G. E. Dinse and J. K. Haseman, Logistic regression analysis of incidental tumor data from animal carcinogenicity experiments. Fundam. Appl. Toxicol. 6, 44-52 (1986).
10. B. McKnight and J. Crowley, Tests for differences in tumor incidence based on animal carcinogenesis experiments. J. Am. Stat. Assoc. 79, 639-648 (1984).
11. P. Armitage, Statistical Methods in Medical Research, pp. 362-365. Wiley, New York (1971).
12. J. J. Gart, K. C. Chu and R. E. Tarone, Statistical issues in interpretation of chronic bioassay tests for carcinogenicity studies. Environ. Health Perspect. 58, 385-392 (1979).
13. J. K. Haseman, Statistical issues in the design, analysis, and interpretation of animal carcinogenicity studies. Environ. Health Perspect. 58, 385-392 (1984).
14. G. N. Rao, J. K. Haseman, S. Grumbein, D. D. Crawford and S. L. Eustis, Growth, body weight, survival, and tumor trends in F344/N rats during an eleven year period. Toxicol. Pathol. 18, 61-70 (1990).
15. 1 mice and F344 rats. Fundam. Appl. Toxicol. 24, 247-259 (1995).
16. P. Bannasch, H. Zerban and H. J. Hacker, Oncocytoma, kidney, rat. In Urinary System, ed. by T. C. Jones, U. Mohr and R. D. Hunt, pp. 49-60. Springer-Verlag, Berlin (1986).
17. J. N. Eble and M. T. Hull, Morphologic features of renal oncocytoma: a light and electron microscopic study. Hum. Pathol. 15, 1054-1061 (1984).
18. 1 mice. Fundam. Appl. Toxicol. 23, 44-52 (1994).
19. 1 Mice. Technical Report No. 393. U.S. Dept. Health & Human. Services, December 1990.
20. 1 Mice. Technical Report No. 436. U.S. Dept. Health & Human. Services, May 1995.
21. K. Hirao, Y. Shinorhara, H. Tsuda, S. Fukushima, M. Takahashi and N. Ito, Carcinogenic activity of quinoline on rat liver. Cancer Res. 36, 329-335 (1976).
22. Y. Shinorhara, T. Ogiso, M. Hananouchi, K. Nakanishi, T. Youshimura and N. Ito, Effect of various factors on the induction of liver tumors in animals by quinoline. Gann 68, 785-796 (1977).
23. E. J. LaVoie, A. Shigematsu and A. Rivenson, The carcinogenicity of quinoline and benzoquinolines in newborn CD-1 mice. Jpn. J. Cancer Res. 78, 139-143 (1987).
24. S. Fukushima, Y. Ishihara, O. Nishio, T. Ogiso, T. Shirai and N. Ito, Carcinogenicities of quinoline derivatives in F344 rats. Cancer Lett. 14, 115-123 (1981).
25. E. J. LaVoie, A. Shigematsu, E. A. Adams, J. Rigotty and D. Hoffman, Tumor-initiating activity of quinoline and methylated quinolines on the skin of SENCAR mice. Cancer Lett. 22, 269-273 (1984).
26. E. J. LaVoie, J. Defaw, M. Fealy, B. M. Way and C. A. McQueen, Genotoxicity of fluoroquinolines and methylquinolines. Carcinogenesis 12(2), 217-220 (1991).
27. M. I. Willems, G. Dubois, D. R. Boyd, R. J. H. Davies, L. Hamilton, J. J. McCullough and P. J. van Bladeren, Comparison of the mutagenicity of quinoline and all monohydroxyquinolines with a series of arene oxide, trans-dihydrodiol, diol epoxide, N-oxide and arene hydrate derivatives of quinoline in the ames/Salmonella microsome test. Mutat. Res. 278, 227-236 (1992).
28. L. T. Burka, J. M. Sanders and H. B. Matthews, Comparative metabolism and disposition ethoxyquin in rat and mouse. II. Metabolism. Xenobiotica 26(6), 597-611 (1996).